Lv2
190 积分 2022-10-30 加入
A Novel Lipid Nanoparticle NBF-006 Encapsulating Glutathione S-Transferase P siRNA for the Treatment of KRAS-Driven Non–small Cell Lung Cancer
21天前
已完结
Abstract ND11: The discovery and characterization of ION-537: A next generation antisense oligonucleotide inhibitor of YAP1 in preclinical cancer models
21天前
已完结
Perspectives on the current and emerging chemical androgen receptor antagonists for the treatment of prostate cancer
21天前
已完结
Preclinical and Clinical Pharmacokinetics of JNJ‐75220795, an siRNA Therapeutic Targeting PNPLA3, for Metabolic Dysfunction‐Associated Steatohepatitis
26天前
已完结
17β-hydroxysteroid dehydrogenases in the progression of nonalcoholic fatty liver disease
26天前
已完结
Unveiling MASH: A Comprehensive Review Highlighting Experimental Insights, Molecular Pathogenesis, and Therapeutic Approaches
1个月前
已完结
Resmetirom, the first FDA-approved drug for MASH: From drug discovery and action mechanisms to clinical trials
1个月前
已完结
Future potential therapeutics to treat MASH
1个月前
已完结
Therapeutic landscape of metabolic dysfunction-associated steatohepatitis (MASH)
1个月前
已完结
Dolomiaea souliei ethyl acetate extract protected against α-naphthylisothiocyanate-induced acute intrahepatic cholestasis through regulation of farnesoid x receptor-mediated bile acid metabolism
1个月前
已完结
皖公网安备34019202002308
